Cerevance
1 / 1
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01Jun 24, 2022
Biotechs
10 Promising Biotechs Aiming to Transform Medicine
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PA564Mar 22, 2022
Neurodegenerative Diseases
Uncovering New Drug Targets for Neurological Diseases
Brad Margus
Cerevance
PAO-02-022-CL-10Mar 12, 2022
Clinical Trials
Cerevance Achieves Key Endpoints in Phase 1 Clinical Trial of Novel Parkinson’s Disease Drug CVN424
Cerevance
PR-M05-19-NI-011May 03, 2019
1 / 1